Screening, Surveillance, and Primary Prevention for Colorectal Cancer: A Review of the Recent Literature
Open accessThe DOI matches its Crossref record; 10 of the 10 references it cites were found in a registry or an index.
Abstract
Colorectal cancer (CRC) remains a major clinical and public health challenge, with 148,810 new cases and 49,960 deaths expected in the United States in 2008.1Jemal A. Siegel R. Ward E. et al.Cancer statistics, 2008.CA Cancer J Clin. 2008; 58: 71-96Crossref PubMed Scopus (10253) Google Scholar The field of CRC research is dynamic and expanding in several directions, encompassing areas of clinical and outcomes research, epidemiology, public health, and molecular sciences. In this review, we summarize important developments in CRC screening and surveillance over the past several years and discuss the present state of the art of this field. According to the National Cholesterol Education Program's Adult Treatment panel III, metabolic syndrome is the presence of 3 or more of the following factors: hypertension (blood pressure of 130/85 mm Hg or greater), central adiposity (waist circumference greater than 102 cm in men or greater than 88 cm in women or a body mass index [BMI] greater than 27 [kg/m2]), low high-density lipoprotein (HDL) cholesterol (HDL <40 mg/dL in men or <50 mg/dL in women), hypertriglyceridemia (150 mg/dL or greater), and impaired glucose tolerance (fasting serum glucose of 110 mg/dL or greater).2Cheng A.Y. Leiter L.A. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.Curr Opin Cardiol. 2006; 21: 400-404Crossref PubMed Scopus (53) Google Scholar Colorectal neoplasia has been associated with markers of glucose and insulin control; insulin resistance, which is the cornerstone of the metabolic syndrome, may be the mechanism by which several risk factors (obesity, diabetes mellitus, [lack of] fitness) affect colorectal carcinogenesis.3Kaaks R. Toniolo P. Akhmedkhanov A. et al.Serum C-peptide, insulin-like growth factor (IGF)-I, IGF-binding proteins, and colorectal cancer risk in women.J Natl Cancer Inst. 2000; 92: 1592-1600Crossref PubMed Google Scholar, 4Saydah S.H. Platz E.A. Rifai N. et al.Association of markers of insulin and glucose control with subsequent colorectal cancer risk.Cancer Epidemiol Biomarkers Prev. 2003; 12: 412-418PubMed Google Scholar Four of the most recent studies of metabolic syndrome and CRC are summarized in Table 1.5Ahmed R.L. Schmitz K.H. Anderson K.E. et al.The metabolic syndrome and risk of incident colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2006; 107: 28-36Google Scholar, 6Chiu H.-M. Lin J.-T. Shun C.-T. et al.Association of metabolic syndrome with proximal and synchronous colorectal neoplasm.Clin Gastroenterol Hepatol. 2007; 5: 221-229Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar, 7Kim J.H. Lim Y.J. Kim Y.-H. et al.Is metabolic syndrome a risk factor for colorectal adenoma?.Cancer Epidemiol Biomarkers Prev. 2007; 16: 1563-1566Crossref Scopus (149) Google Scholar, 8Sturmer T. Buring J.E. Lee I.-M. et al.Metabolic abnormalities and risk for colorectal cancer in the Physicians' Health Study.Cancer Epidemiol Biomarkers Prev. 2006; 15: 2391-2397Crossref PubMed Scopus (0) Google Scholar These studies comprise different study populations and different study designs but use the same or comparable definitions of metabolic syndrome, similar methods of analysis, and either adenoma or cancer as outcomes. The study findings are quite consistent: either the metabolic syndrome or its components increase the risk for colorectal neoplasia (both adenomas and cancer) by approximately 50%. The effect of metabolic syndrome on neoplasia risk appears to be greater in men than in women. The relationship between metabolic syndrome and large bowel location of neoplasia reported by Chiu et al6Chiu H.-M. Lin J.-T. Shun C.-T. et al.Association of metabolic syndrome with proximal and synchronous colorectal neoplasm.Clin Gastroenterol Hepatol. 2007; 5: 221-229Abstract Full Text Full Text PDF PubMed Scopus (69) Google Scholar is interesting and requires validation in analyses of other populations.Table 1Summary of Selected Studies on Metabolic Syndrome and Risk of Colorectal NeoplasiaFirst author, year (ref)Study populationStudy designCriteria for metabolic syndromeOutcomesType of risk modelMain findingsAhmed, 2006 (5Ahmed R.L. Schmitz K.H. Anderson K.E. et al.The metabolic syndrome and risk of incident colorectal cancer.Cancer Epidemiol Biomarkers Prev. 2006; 107: 28-36Google Scholar)14,109 subjects from the Atherosclerosis Risk in Communities (ARIC) multicenter study)CohortATP IIIColorectal cancerMultiple logistic model, adjusted for age, gender, family history of CRC, physical activity, NSAID use, aspirin use, smoking, alcohol use, hormone replacement useMS associated with increased risk of CRC (age and gender adjusted RR, 1.49; 95% CI: 1.0–2.4), which attenuated after multivariate adjustment (RR, 1.39; 95% CI: 0.9–2.2). Adjusted risk was increased in men (RR, 1.78; 95% CI: 1.02–3.6) but not in women (RR, 1.16; 95% CI: 0.6–2.2)Sturmer, 2006 (8Sturmer T. Buring J.E. Lee I.-M. et al.Metabolic ab
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
WINAWER, S. (2003) · Gastroenterology · doi:10.1053/gast.2003.50044 · Cited by 2,143
Quality indicators for colonoscopy
Rex, D. K., Schoenfeld, P. S., Cohen, J., Pike, I. M., Adler, D. G., Fennerty, M. B., Lieb, J. G., Park, W. G., Rizk, M. K., Sawhney, M. S., et al. (2015) · Gastrointestinal Endoscopy · doi:10.1016/j.gie.2014.07.058 · Cited by 1,764
Self-citationScreening for the Lynch syndrome (hereditary nonpolyposis colorectal cancer)
Hampel, H., Frankel, W. L., Martin, E., Arnold, M., Khanduja, K., Kuebler, P., Nakagawa, H., Sotamaa, K., Prior, T. W., Westman, J., et al. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa043146 · Cited by 1,408
Folic Acid for the Prevention of Colorectal Adenomas: A Randomized Clinical Trial
Cole, B. F., Baron, J. A., Sandler, R. S., Haile, R. W., Ahnen, D. J., Bresalier, R. S., McKeown-Eyssen, G., Summers, R. W., Rothstein, R. I., Burke, C. A., et al. (2007) · JAMA · doi:10.1001/jama.297.21.2351 · Cited by 929
Flossmann, E., & Rothwell, P. M. (2007) · The Lancet · doi:10.1016/s0140-6736(07)60747-8 · Cited by 820
Cook, N. R., Lee, I.-M., Gaziano, J. M., Gordon, D., Ridker, P. M., Manson, J. E., Hennekens, C. H., & Buring, J. E. (2005) · JAMA · doi:10.1001/jama.294.1.47 · Cited by 796
Follow-up strategies for patients treated for non-metastatic colorectal cancer
Jeffery, M., Hickey, B. E., & Hider, P. N. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd002200.pub2 · Cited by 205
Green, R. J., Metlay, J. P., Propert, K., Catalano, P. J., Macdonald, J. S., Mayer, R. J., & Haller, D. G. (2002) · Annals of Internal Medicine · doi:10.7326/0003-4819-136-4-200202190-00005 · Cited by 161
Cigarettes, alcohol, coffee, and caffeine as risk factors for colorectal adenomatous polyps
Lee, W. C., Neugut, A. I., Garbowski, G. C., Forde, K. A., Treat, M. R., Ways, J. D., & Fenoglio-Preiser, C. (1993) · Annals of Epidemiology · doi:10.1016/1047-2797(93)90025-y · Cited by 87
Cited by
Role of the Serrated Pathway in Colorectal Cancer Pathogenesis
Leggett, B., & Whitehall, V. (2010) · Gastroenterology · doi:10.1053/j.gastro.2009.12.066 · Cited by 977
CIMP Status of Interval Colon Cancers: Another Piece to the Puzzle
Arain, M. A., Sawhney, M., Sheikh, S., Anway, R., Thyagarajan, B., Bond, J. H., & Shaukat, A. (2010) · American Journal of Gastroenterology · doi:10.1038/ajg.2009.699 · Cited by 382
Sensitive digital quantification of DNA methylation in clinical samples
Li, M., Chen, W.-D., Papadopoulos, N., Goodman, S. N., Bjerregaard, N. C., Laurberg, S., Levin, B., Juhl, H., Arber, N., Moinova, H., et al. (2009) · Nature Biotechnology · doi:10.1038/nbt.1559 · Cited by 341
Yeoh, K.-G., Ho, K.-Y., Chiu, H.-M., Zhu, F., Ching, J. Y. L., Wu, D.-C., Matsuda, T., Byeon, J.-S., Lee, S.-K., Goh, K.-L., et al. (2011) · Gut · doi:10.1136/gut.2010.221168 · Cited by 331
Strum, W. B. (2016) · New England Journal of Medicine · doi:10.1056/nejmra1513581 · Cited by 312
Metadata
- Authors
- Kahi, C. J., Rex, D. K., & Imperiale, T. F.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2008-08
- Volume
- 135
- Issue
- 2
- Pages
- 380-399
- ISSN
- 0016-5085 (ISSN-L)
- OpenAlex
- W2087617371
- Cited by
- 133
- References
- 10
- FWCI
- 8.93
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.